共 44 条
[1]
Kanji N., Hardon A., Harnmeijer J.W., Mamdani M., Walt G., Drugs Policy in Developing Countries, (1992)
[2]
Another Development in Pharmaceuticals. Development Dialogue, Volume 2, (1985)
[3]
Frisher M., Martino O., Crome I., Croft P., Trends in drug misuse recorded in primary care in the UK from 1998 to 2005, J Public Health (Oxf), 31, 1, pp. 69-73, (2009)
[4]
Equitable access to essential medicines: a framework for collective action, (2004)
[5]
Cameron A., Ewen M., Ross-Degnan D., Ball D., Laing R., Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis, Lancet, 373, 9659, pp. 240-249, (2009)
[6]
Dukes MNG H.R.F.M., de Joncheere C.P., Rietveld A.H., Prices, affordability and cost containment, (2003)
[7]
't Hoen E.F.M., The Global Politics of Pharmaceutical Monopoly Power, (2009)
[8]
Delivering on the Global Partnership for Achieving the Millennium Development Goals, in MDG Gap Task Force Report, (2008)
[9]
Calabrese L.H., Changing patterns of morbidity and mortality in HIV disease, Cleveland Clinical Journal of Medicine, 68, 2, pp. 109-110, (2001)
[10]
How to develop and implement a national drug policy, in WHO Policy Perspectives on Medicines, (2003)